1
|
Singh JA, Saag KG, Bridges SL Jr, Akl EA,
Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M,
Shmerling RH, et al: 2015 American College of Rheumatology
Guideline for the Treatment of Rheumatoid Arthritis. Arthritis
Rheumatol. 68:1–26. 2016.PubMed/NCBI View Article : Google Scholar
|
2
|
Jin S, Li M, Fang Y, Li Q, Liu J, Duan X,
Liu Y, Wu R, Shi X, Wang Y, et al: CREDIT Co-authors: Chinese
Registry of rheumatoid arthritis (CREDIT): II prevalence and risk
factors of major comorbidities in Chinese patients with rheumatoid
arthritis. Arthritis Res Ther. 19(251)2017.PubMed/NCBI View Article : Google Scholar
|
3
|
de Achaval S and Suarez-Almazor ME:
Treatment adherence to disease-modifying antirheumatic drugs in
patients with rheumatoid arthritis and systemic lupus
erythematosus. Int J Clin Rheumatol. 5:313–326. 2010.PubMed/NCBI View Article : Google Scholar
|
4
|
Malmström V, Catrina AI and Klareskog L:
The immunopathogenesis of seropositive rheumatoid arthritis: From
triggering to targeting. Nat Rev Immunol. 17:60–75. 2017.PubMed/NCBI View Article : Google Scholar
|
5
|
Catrina AI, Joshua V, Klareskog L and
Malmström V: Mechanisms involved in triggering rheumatoid
arthritis. Immunol Rev. 269:162–174. 2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Zelenay S, van der Veen AG, Böttcher JP,
Snelgrove KJ, Rogers N, Acton SE, Chakravarty P, Girotti MR, Marais
R, Quezada SA, et al: Cyclooxygenase-dependent tumor growth through
evasion of immunity. Cell. 162:1257–1270. 2015.PubMed/NCBI View Article : Google Scholar
|
7
|
Depboylu C, Weihe E and Eiden LE: COX1 and
COX2 expression in non-neuronal cellular compartments of the rhesus
macaque brain during lentiviral infection. Neurobiol Dis.
42:108–115. 2011.PubMed/NCBI View Article : Google Scholar
|
8
|
Yang CM, Chen YW, Chi PL, Lin CC and Hsiao
LD: Resveratrol inhibits BK-induced COX-2 transcription by
suppressing acetylation of AP-1 and NF-κB in human rheumatoid
arthritis synovial fibroblasts. Biochem Pharmacol. 132:77–91.
2017.PubMed/NCBI View Article : Google Scholar
|
9
|
Walther U, Emmrich K, Ramer R, Mittag N
and Hinz B: Lovastatin lactone elicits human lung cancer cell
apoptosis via a COX-2/PPARγ-dependent pathway. Oncotarget.
7:10345–10362. 2016.PubMed/NCBI View Article : Google Scholar
|
10
|
Lowin T, Apitz M, Anders S and Straub RH:
Anti-inflammatory effects of N-acylethanolamines in rheumatoid
arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2
dependent manner. Arthritis Res Ther. 17(321)2015.PubMed/NCBI View Article : Google Scholar
|
11
|
Tang YL, Huang LB, Lin WH, Wang LN, Tian
Y, Shi D, Wang J, Qin G, Li A, Liang YN, et al: Butein inhibits
cell proliferation and induces cell cycle arrest in acute
lymphoblastic leukemia via FOXO3a/p27kip1 pathway. Oncotarget.
7:18651–18664. 2016.PubMed/NCBI View Article : Google Scholar
|
12
|
Obexer P, Geiger K, Ambros PF, Meister B
and Ausserlechner MJ: FKHRL1-mediated expression of Noxa and Bim
induces apoptosis via the mitochondria in neuroblastoma cells. Cell
Death Differ. 14:534–547. 2007.PubMed/NCBI View Article : Google Scholar
|
13
|
Jiang Y, Zou L, Lu WQ, Zhang Y and Shen
AG: Foxo3a expression is a prognostic marker in breast cancer. PLoS
One. 8(e70746)2013.PubMed/NCBI View Article : Google Scholar
|
14
|
Viatte S, Lee JC, Fu B, Espéli M, Lunt M,
De Wolf JN, Wheeler L, Reynolds JA, Castelino M, Symmons DP, et al:
Association between genetic variation in FOXO3 and reductions in
inflammation and disease activity in inflammatory polyarthritis.
Arthritis Rheumatol. 68:2629–2636. 2016.PubMed/NCBI View Article : Google Scholar
|
15
|
Aletaha D, Neogi T, Silman AJ, Funovits J,
Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP,
Cohen MD, et al: 2010 Rheumatoid arthritis classification criteria:
An American College of Rheumatology/European League Against
Rheumatism collaborative initiative. Arthritis Rheum. 62:2569–2581.
2010.PubMed/NCBI View Article : Google Scholar
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
17
|
Narayan N, Owen DR, Mandhair H, Smyth E,
Carlucci F, Saleem A, Gunn RN, Rabiner EA, Wells L, Dakin SG, et
al: Translocator protein as an imaging marker of macrophage and
stromal activation in rheumatoid arthritis pannus. J Nucl Med.
59:1125–1132. 2018.PubMed/NCBI View Article : Google Scholar
|
18
|
Gong G and Mao J: Health-related quality
of life among Chinese patients with rheumatoid arthritis: The
predictive roles of fatigue, functional disability, self-efficacy,
and social support. Nurs Res. 65:55–67. 2016.PubMed/NCBI View Article : Google Scholar
|
19
|
Smith SR, Deshpande BR, Collins JE, Katz
JN and Losina E: Comparative pain reduction of oral non-steroidal
anti-inflammatory drugs and opioids for knee osteoarthritis:
Systematic analytic review. Osteoarthritis Cartilage. 24:962–972.
2016.PubMed/NCBI View Article : Google Scholar
|
20
|
Fan HW, Liu GY, Zhao CF, Li XF and Yang
XY: Differential expression of COX-2 in osteoarthritis and
rheumatoid arthritis. Genet Mol Res. 14:12872–12879.
2015.PubMed/NCBI View Article : Google Scholar
|
21
|
Peng A, Lu X, Huang J, He M, Xu J, Huang H
and Chen Q: Rheumatoid arthritis synovial fibroblasts promote
TREM-1 expression in monocytes via COX-2/PGE 2 pathway. Arthritis
Res Ther. 21(169)2019.PubMed/NCBI View Article : Google Scholar
|
22
|
Roubille C, Richer V, Starnino T, McCourt
C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, et al:
The effects of tumour necrosis factor inhibitors, methotrexate,
non-steroidal anti-inflammatory drugs and corticosteroids on
cardiovascular events in rheumatoid arthritis, psoriasis and
psoriatic arthritis: A systematic review and meta-analysis. Ann
Rheum Dis. 74:480–489. 2015.PubMed/NCBI View Article : Google Scholar
|
23
|
Nissen SE, Yeomans ND, Solomon DH, Lüscher
TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski
KE, et al: PRECISION Trial Investigators: Cardiovascular safety of
celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med.
375:2519–2529. 2016.PubMed/NCBI View Article : Google Scholar
|
24
|
Codogno P and Morel E: FOXO3a provides a
quickstep from autophagy inhibition to apoptosis in cancer therapy.
Dev Cell. 44:537–539. 2018.PubMed/NCBI View Article : Google Scholar
|
25
|
Turrel-Davin F, Tournadre A, Pachot A,
Arnaud B, Cazalis MA, Mougin B and Miossec P: FoxO3a involved in
neutrophil and T cell survival is overexpressed in rheumatoid blood
and msynovial tissue. Ann Rheum Dis. 69:755–760. 2010.PubMed/NCBI View Article : Google Scholar
|
26
|
Yoshida K, Matsui K, Nakano H, Oshikawa H,
Utsunomiya M, Kobayashi T, Kimura M, Deshpande GA and Kishimoto M:
Response to ‘Pain persists in DAS28 rheumatoid arthritis remission
but not in ACR/EULAR remission: A longitudinal observational
study’. Arthritis Res Ther. 13(405)2011.PubMed/NCBI View
Article : Google Scholar
|
27
|
Sheehy C, Evans V, Hasthorpe H and
Mukhtyar C: Revising DAS28 scores for remission in rheumatoid
arthritis. Clin Rheumatol. 33:269–272. 2014.PubMed/NCBI View Article : Google Scholar
|
28
|
Shimada K, Komiya A, Yokogawa N, Nishino
J, Sugii S and Tohma S: Impact of the size and number of swollen
joints on serum C-reactive protein level and erythrocyte
sedimentation rate in rheumatoid arthritis: A cross-sectional study
in Japan. Clin Rheumatol. 36:427–431. 2017.PubMed/NCBI View Article : Google Scholar
|